Early Cancer Detection - RGCC Test
What is the RGCC Test?
The RGCC test is a blood test that uses advanced DNA sequencing methods to detect the DNA methylation pattern of circulating tumor DNA (ctDNA) in blood samples in order to both confirm the presence of cancer and give quantitative data.
The RGCC test has been validated with four (4) cancer tissues of origin: breast, colon, liver and lung cancers. The presence of other cancer types may also result in an elevated RGCC Score.
Why should I get an RGCC Testing?
Since this test detects very small amounts of circulating cancer cells in the body, it leads to early detection and treatment much, much before anything would show up on Xrays, or CT scans or any other traditional test. It also picks up on cancer recurrences in the very, very early stages and thus results in a higher rate of treatment success.
You can find more details about this and IvyGene testing here.
Are there any downsides to this test?
None. It’s a simple blood test that can be easily done in the office, saving you travel time to a laboratory.
Schedule your free 15 min consultation with our physician today to find out more about this great test!
